Aquestive Therapeutics
AQST
AQST
114 hedge funds and large institutions have $154M invested in Aquestive Therapeutics in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
1.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
46
Reduced
33
Closed
22
Calls
$1.89M
Puts
$605K
Net Calls
+$1.28M
Net Calls Change
-$3.21M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$2.33M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.21M |
| 3 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$1.79M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.17M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$1.08M |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$10.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$2.63M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$2.25M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.74M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.65M |
